STORIES OF STRENGTH
2009 Grant Recipients
Career Development Award
 |
I-Ching Wang, PhD, Cincinnati Children's Hospital Medical Center Dr. Wang seeks to understand how FoxM1, a protein that helps regulate cell growth in normal cells, may also contribute to uncontrolled growth in cancerous cells. Although FoxM1 is known to play a role in the development of lung cancer, the exact mechanisms by which it is acting are not yet defined. Dr. Wang’s research seeks to define FoxM1’s actions in lung cancer initiation, ultimately to help facilitate development of novel therapies directed towards the protein. This grant is supported by the National Lung Cancer Partnership. |
Research Grants
 |
Prasad Adusumilli, MD, Memorial Sloan-Kettering Cancer Center Dr. Adusumilli aims to improve treatment for patients with Visceral Pleural Invasion, a condition that affects one in four early stage lung cancer patients, where cancer cells spread to the membrane covering the lungs’ surface. The goal of his research is to develop a novel lung cancer treatment by genetically modifying patients’ own immune cells (T cells) to eliminate their tumor cells. This grant is supported by the National Lung Cancer Partnership and LUNGevity Foundation. |
 |
Lee Goodglick, PhD, University of California, Los Angeles Dr. Goodglick will focus on how estrogen may drive some lung tumors to grow and become more deadly. Aromatase-inhibitor drugs, which have long been used to treat breast cancer by decreasing estrogen levels in patients, will be studied in pre-clinical models to determine their effectiveness in treating lung cancer. Additional research will use new technologies to study lung tumor tissues to determine other steps in the estrogen stimulation pathway that affect tumor progression. This grant is supported by the National Lung Cancer Partnership and LUNGevity Foundation. |
Lung Cancer Survivorship Research Grant
 |
Janette Vardy, MD, PhD, University of Sydney in Sydney, Australia |
